- Home
- MDGL vs PCOR Comparison
MDGL vs PCOR Comparison
Compare MDGL & PCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | PCOR |
|---|---|---|
| Founded | 2011 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 9.6B |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MDGL | PCOR |
|---|---|---|
| Price | $426.48 | $77.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 25 |
| Target Price | ★ $688.94 | $86.27 |
| AVG Volume (30 Days) | 528.6K | ★ 3.4M |
| Earning Date | 11-03-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.94 |
| EPS | N/A | ★ 0.02 |
| Revenue | $180,133,000.00 | ★ $1,322,509,000.00 |
| Revenue This Year | $65.40 | $17.88 |
| Revenue Next Year | $37.72 | $17.50 |
| P/E Ratio | ★ N/A | $3,879.50 |
| Revenue Growth | N/A | ★ 14.83 |
| 52 Week Low | $353.54 | $38.03 |
| 52 Week High | $615.00 | $79.80 |
Technical Indicators
Market Signals| Indicator | MDGL | PCOR |
|---|---|---|
| Relative Strength Index (RSI) | 42.65 | 83.21 |
| Support Level | $416.21 | $46.64 |
| Resistance Level | $553.95 | $79.80 |
| Average True Range (ATR) | 24.47 | 2.88 |
| MACD | 3.66 | 1.19 |
| Stochastic Oscillator | 57.55 | 86.60 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About PCOR Procore Technologies Inc.
Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.